Research
Scientific articles on peptide research, documentation, purity, and traceability.
Alpha Research
Fundamentals
Technical Glossary: Peptide Chemistry, Pharmacokinetics, and Research Documentation Terms
Technical reference of essential terms for researchers working with synthetic peptides: precise definitions of analytical parameters (NPC, HPLC-UV, ESI-MS, LAL), pharmacological concepts (Ki, EC50, Bmax, kon/koff), synthesis terminology (SPPS, Fmoc, resin loading), and lot documentation parameters required in preclinical protocols.
Alpha Research
Fundamentals
Clinical-Grade Peptide Supply Chains: Documentation, Traceability, and CoA Standards
Analysis of criteria defining a research-grade peptide supply chain: lot documentation standards, required analytical methods (HPLC, MS, LAL), endotoxin control, cold-chain custody, and minimum elements of a defensible certificate of analysis for preclinical and regulatory environments.
Alpha Research
Fundamentals
2026 Research Frontiers: GLP-1/GIP Triple Agonists, Mitochondrial Peptides, and Senolytic Peptide Agents
Analysis of the three most active areas of peptide research in 2026: triple incretin receptor agonism (GLP-1R/GIPR/GCGR) with retatrutide as the clinical prototype, mitochondrial peptidomics with elamipretide and MOTS-c as biogenesis agents, and senolytic peptides based on FOXO4-DRI sequences for senescent cell elimination.
Alpha Research
Fundamentals
HPLC Purity, Mass Spectrometry Identity, and Lot Documentation Standards in Research Peptides
Technical review of analytical methods defining research peptide quality: HPLC-UV/DAD chromatography at 214 nm, identity confirmation by ESI-MS or MALDI-TOF, endotoxin assays, net peptide content (NPC), and minimum CoA parameters required for reproducible preclinical protocols.
Alpha Research
Fundamentals
Synthetic vs Endogenous Peptides: Stability, Selectivity, and Research Utility
Comparative analysis of endogenous peptides and their synthetic analogues: differences in proteolytic resistance, receptor affinity and selectivity, pharmacokinetic profile, and analytical purity control that determine the advantage of synthetic analogues in reproducible preclinical research.
Alpha Research
Fundamentals
Milestones in Synthetic Peptide Chemistry: From Merrifield SPPS to GLP-1 Agonist Approvals
Scientific chronology of peptide synthesis development: from Emil Fischer's solution synthesis (1901) to Merrifield's SPPS (1963), Fmoc protection introduction (1972), du Vigneaud's synthetic oxytocin (1953), and second- and third-generation GLP-1/GIPR agonists approved 2005–2023.
Alpha Research
Fundamentals
Classification of Research Peptides by Mechanism Class and Receptor Profile
Systematic classification of research peptides by mechanism of action, target receptor subtype, and signaling consequences: GPCR agonists, integrin modulators, mitochondrial peptides, antimicrobials, and GH secretagogues, with pharmacological profile data for each category.
Alpha Research
Fundamentals
Structural and Functional Differentiation of Peptides, Proteins, and Amino Acid Conjugates
Analysis of biochemical and functional boundaries between peptides, polypeptides, proteins, and amino acid conjugates: how molecular weight, folding, proteolytic stability, and synthesis requirements determine the differential utility of each class in preclinical models.
Alpha Research
Fundamentals
Receptor Binding, Signal Transduction, and Measurable Endpoints in Peptide Research
Analysis of kinetic and thermodynamic determinants of peptide-receptor interaction, activated intracellular signaling pathways (GPCR/β-arrestin, PI3K/Akt, MAPK/ERK, NF-κB), and experimental design criteria enabling scientifically valid interpretation of preclinical endpoints.
Alpha Research
Fundamentals
Peptide Structure, Sequence Integrity, and Lot-Level Quality in Research
Technical analysis of primary peptide structure, physicochemical determinants of stability, and documented quality parameters — HPLC-UV/MS purity, counterion form, lot traceability, and certificate of analysis — that define peptide utility in preclinical protocols.